Malchoff C D, Reardon G, MacGillivray D C, Yamase H, Rogol A D, Malchoff D M
Department of Surgery, University of Connecticut Health Center, Farmington 06030-1110.
J Clin Endocrinol Metab. 1994 Mar;78(3):803-6. doi: 10.1210/jcem.78.3.8126161.
The McCune-Albright syndrome (MAS) is characterized clinically by polyostotic fibrous dysplasia, café-au-lait skin lesions, sexual precocity, and various other endocrinopathies. Recent investigations suggest an etiological role for embryonic somatic missense mutations that predict the substitution of a His or Cys for Arg at amino acid 201 of the Gs alpha-subunit (Gs alpha). Identification of these mutations in affected tissues is a sensitive assay that may help define a more complete clinical spectrum of the MAS. We investigated a woman who developed fibrous dysplasia 24 yr after premature menstruation. To determine if this was an unusual MAS variant, DNA and RNA were analyzed from affected and unaffected tissues. From samples of affected rib and normal rib DNA was extracted, amplified by polymerase chain reaction, subcloned, and sequenced. RNA was extracted from affected bone, reverse transcribed, amplified by polymerase chain reaction, subcloned, and sequenced. DNA sequence predicting a His for Arg substitution at Gs alpha amino acid 201 was found in 47% of the recombinant plasmids from DNA of affected bone and 17% of the plasmids from DNA of unaffected bone; a significant (P < 0.05) difference in frequency. The His201 substitution was found in 42% of the recombinant plasmids from RNA of affected bone. We conclude that this clinical variant is qualitatively indistinguishable from presentations of the complete MAS.
McCune-Albright综合征(MAS)的临床特征为多骨纤维发育不良、牛奶咖啡斑皮肤损害、性早熟以及各种其他内分泌疾病。最近的研究表明,胚胎体细胞错义突变在病因学上起作用,这些突变预测在Gsα亚基(Gsα)的第201位氨基酸处组氨酸或半胱氨酸取代精氨酸。在受影响组织中鉴定这些突变是一种敏感的检测方法,可能有助于确定MAS更完整的临床谱。我们研究了一名女性,她在月经初潮过早24年后出现了纤维发育不良。为了确定这是否是一种不寻常的MAS变异型,对受影响和未受影响的组织进行了DNA和RNA分析。从受影响的肋骨和正常肋骨样本中提取DNA,通过聚合酶链反应扩增,亚克隆并测序。从受影响的骨骼中提取RNA,逆转录,通过聚合酶链反应扩增,亚克隆并测序。在来自受影响骨骼DNA的47%的重组质粒和来自未受影响骨骼DNA的17%的质粒中发现了预测在Gsα氨基酸201处组氨酸取代精氨酸的DNA序列;频率存在显著(P<0.05)差异。在来自受影响骨骼RNA的42%的重组质粒中发现了His201取代。我们得出结论,这种临床变异型在性质上与完整MAS的表现无法区分。